Autolus Therapeutics (AUTL) Non Operating Income (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Non Operating Income came in at -$19.0 million in Q4 2025, down 138.31% YoY from $49.7 million in Q4 2024, and down 173.5% on a QoQ basis from -$7.0 million in Q3 2025.
Autolus Therapeutics (AUTL) Non Operating Income (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Non Operating Income data on file, last reported at -$19.0 million in Q4 2025.
- Quarterly Non Operating Income fell 138.31% year-over-year to -$19.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15.0 million (down 167.35% YoY) and the FY2025 annual result came in at -$15.0 million, down 167.34% from the prior year.
- Non Operating Income retreated to -$19.0 million in Q4 2025, from -$7.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $49.7 million in Q4 2024 to a low of -$23.9 million in Q4 2023.
- A 5-year average of -$1.4 million and a median of -$1.5 million in 2021 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income sank 1959.23% — and 2025, when it soared 1834.6%.
- Tracing AUTL's Non Operating Income over 5 years: stood at -$1.0 million in 2021, then surged by 505.09% to $4.2 million in 2022, then sank by 666.79% to -$23.9 million in 2023, then soared by 307.82% to $49.7 million in 2024, then sank by 138.31% to -$19.0 million in 2025.
- The last three Non Operating Income figures came in at -$19.0 million (Q4 2025), -$7.0 million (Q3 2025), and $13.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 5.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.19 Mn |
| Dec 31, 2025 | -19.05 Mn |
| Sep 30, 2025 | -6.97 Mn |
| Jun 30, 2025 | 13.70 Mn |
| Mar 31, 2025 | -2.70 Mn |
| Dec 31, 2024 | 49.72 Mn |
| Sep 30, 2024 | -14.20 Mn |
| Jun 30, 2024 | 708,000.00 |
| Mar 31, 2024 | -13.94 Mn |
| Dec 31, 2023 | -23.92 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | -677,000.00 |
| Dec 31, 2022 | 4.22 Mn |
| Sep 30, 2022 | -5.43 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Mar 31, 2022 | -902,000.00 |
| Dec 31, 2021 | -1.04 Mn |
| Sep 30, 2021 | 979,000.00 |
| Jun 30, 2021 | -1.81 Mn |